OUTLOOK THERAPEUTICS, INC. Noncontrolling Interest, Decrease from Deconsolidation
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Noncontrolling Interest, Decrease from Deconsolidation of $654.42 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2017-12-29.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2017-12-29
- OUTLOOK THERAPEUTICS, INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2016-09-30 was $0.00.
- OUTLOOK THERAPEUTICS, INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2016-06-30 was $0.00.
- OUTLOOK THERAPEUTICS, INC. noncontrolling interest, decrease from deconsolidation for fiscal 2016 was $654.42K.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 6 month | Noncontrolling Interest, Decrease from Deconsolidation 9 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | $0.00 derived: sum of 2 quarters · filed 2017-12-29 | $654.42K 10-K · filed 2017-12-29 | |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $654.42K 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $654.42K 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |